Search research articles
Contact Us
Filters
Showing results (11-20 of 106) with videos related to
Page
of 11
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
December 16, 2022
In Regard to Fornacon-Wood et al
Amit K Chowdhry, Deborah Mayo, Stephanie L Pugh, et al.
Journal of the National Cancer Institute. Monographs
|
February 24, 2025
On the use of external controls in clinical trials
Michelle M Nuño, Stephanie L Pugh, Lingyun Ji, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 18, 2018
Attrition in NRG Oncology's Radiation-Based Clinical Trials
Connie M Ulrich, Snehal Deshmukh, Stephanie L Pugh, et al.
Journal of the National Cancer Institute. Monographs
|
February 24, 2025
Practical design considerations for cluster randomized controlled trials: lessons learned in community oncology research
Emily V Dressler, Stephanie L Pugh, Heather J Gunn, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
September 7, 2020
Do reminder emails and past due notifications improve patient completion and institutional data submission for patient-reported outcome measures?
Stephanie L Pugh, Joseph P Rodgers, Jennifer Moughan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 27, 2020
Characteristics of Participation in Patient-Reported Outcomes and Electronic Data Capture Components of NRG Oncology Clinical Trials
Stephanie L Pugh, Joseph P Rodgers, Katherine A Yeager, et al.
Journal of the National Cancer Institute. Monographs
|
February 24, 2025
When to adjust for multiplicity in cancer clinical trials
Joseph M Unger, Gina L Mazza, Mohamed I Elsaid, et al.
European Urology
|
July 18, 2024
Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized Trials
Daniel E Spratt, Vinnie Y T Liu, Angela Y Jia, et al.
Journal of Neuro-Oncology
|
October 23, 2016
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma
Mark R Gilbert, Stephanie L Pugh, Ken Aldape, et al.
Neuro-Oncology Practice
|
August 7, 2019
The association of health-related quality of life and cognitive function in patients receiving memantine for the prevention of cognitive dysfunction during whole-brain radiotherapy
Nadia N Laack, Stephanie L Pugh, Paul D Brown, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 106) with videos related to
Sort By:
Page
of 11
International Journal of Radiation Oncology, Biology, Physics
|
December 16, 2022
In Regard to Fornacon-Wood et al
Amit K Chowdhry, Deborah Mayo, Stephanie L Pugh, et al.
Journal of the National Cancer Institute. Monographs
|
February 24, 2025
On the use of external controls in clinical trials
Michelle M Nuño, Stephanie L Pugh, Lingyun Ji, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 18, 2018
Attrition in NRG Oncology's Radiation-Based Clinical Trials
Connie M Ulrich, Snehal Deshmukh, Stephanie L Pugh, et al.
Journal of the National Cancer Institute. Monographs
|
February 24, 2025
Practical design considerations for cluster randomized controlled trials: lessons learned in community oncology research
Emily V Dressler, Stephanie L Pugh, Heather J Gunn, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
September 7, 2020
Do reminder emails and past due notifications improve patient completion and institutional data submission for patient-reported outcome measures?
Stephanie L Pugh, Joseph P Rodgers, Jennifer Moughan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 27, 2020
Characteristics of Participation in Patient-Reported Outcomes and Electronic Data Capture Components of NRG Oncology Clinical Trials
Stephanie L Pugh, Joseph P Rodgers, Katherine A Yeager, et al.
Journal of the National Cancer Institute. Monographs
|
February 24, 2025
When to adjust for multiplicity in cancer clinical trials
Joseph M Unger, Gina L Mazza, Mohamed I Elsaid, et al.
European Urology
|
July 18, 2024
Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized Trials
Daniel E Spratt, Vinnie Y T Liu, Angela Y Jia, et al.
Journal of Neuro-Oncology
|
October 23, 2016
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma
Mark R Gilbert, Stephanie L Pugh, Ken Aldape, et al.
Neuro-Oncology Practice
|
August 7, 2019
The association of health-related quality of life and cognitive function in patients receiving memantine for the prevention of cognitive dysfunction during whole-brain radiotherapy
Nadia N Laack, Stephanie L Pugh, Paul D Brown, et al.
Page
of 11